AnaptysBio Inc
ANAB
Market Cap$569.18M
Close$
$-14.56
166.5% downside
Current Fair Value
166.5% downsideOvervalued by 166.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $569.18 Million |
|---|---|
| Enterprise Value | $871.34 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-5.12 |
| Beta | -0.19 |
| Outstanding Shares | 28,810,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.42 |
|---|---|
| PEG | 25.67 |
| Price to Sales | 5.48 |
| Price to Book Ratio | -10.95 |
| Enterprise Value to Revenue | 7.07 |
| Enterprise Value to EBIT | -11.64 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.4 |
| Debt to Equity | -7.74 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About AnaptysBio Inc
CEO: Hamza Suria